Renaissance Capital logo

Bausch + Lomb Priced, NYSE: BLCO

Leading supplier of contact lenses and eyecare products.

Industry: Health Care

Latest Trade: $14.93 0.00 (0.0%)

First Day Return: +11.1%

Return from IPO: -17.1%

Industry: Health Care

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better. Our comprehensive portfolio of over 400 products is fully integrated and built to serve our customers across the full spectrum of their eye health needs throughout their lives. Our iconic brand is built on the deep trust and loyalty of our customers established over our nearly 170-year history. We have a significant global research, development, manufacturing and commercial footprint of approximately 12,500 employees and a presence in approximately 100 countries, extending our reach to billions of potential customers across the globe. We have long been associated with many of the most significant advances in eye health, and we believe we are well positioned to continue leading the advancement of eye health in the future. Our iconic and enduring brands are among the most recognized and most trusted in the industry. Since our beginnings in 1853 as an optical goods shop in Rochester, New York, we have remained focused on advancing eye health for people all over the world.
more less
IPO Data
IPO File Date 01/13/2022
Offer Price $18.00
Price Range $21.00 - $24.00
Offer Shares (mm) 35.0
Deal Size ($mm) $630
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/05/2022
Offer Price $18.00
Price Range $21.00 - $24.00
Offer Shares (mm) 35.0
Deal Size ($mm) $630
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
Morgan Stanley
Goldman Sachs
more
Company Data
Headquarters Vaughan, Canada
Founded 1853
Employees 19,600
Website www.bausch.com

Bausch + Lomb (BLCO) Performance